クリングルファーマ株式会社.

NEWS

お知らせ


Warning: Invalid argument supplied for foreach() in /home/r3716923/public_html/kringle-pharma.com/wp-content/themes/kringle_pharma/view/single/default.php on line 21
2020.07.20

SCI Phase III start PDF

Kringle initiates Phase 3 clinical trial of recombinant human HGF for the treatment of acute spinal cord injury.